Lonasyl Tablet (Terbinafine Hydrochloride)
Terbinafine Hydrochloride
Prescription medication
Bioneer Co., Ltd.
MFDS item code 200400578 · Notified 2004.01.26
This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of onychomycosis, dermatomycosis (e.g., tinea pedis and tinea corporis), and tinea capitis in children
This medication is used in adults for the treatment of tinea pedis, tinea corporis, tinea cruris (ringworm), and onychomycosis caused by dermatophytes. It is also used in children for the treatment of tinea capitis.
Administer terbinafine at a dose of 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital or plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. In cases involving the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. Treatment of toenail infections usually requires 3 months, but may take 6 months or longer in some patients. The treatment period may be longer in patients with slow nail growth. For patients with a creatinine clearance of less than 50 mL/min, reduce the daily dose by 1/2.
Administer to children 2 years of age and older. Administration is not recommended for children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks 1) Body weight less than 20 kg (under 5 years of age): Administer 62.5 mg once daily. 2) Body weight 20~40 kg (5~12 years of age): Administer 125 mg once daily. 3) Body weight greater than 40 kg (over 12 years of age): Administer 250 mg once daily.
This medication is not recommended for patients with chronic liver disease or active liver disease. Be sure to check for liver disease before using this drug, and a liver function test is recommended for all patients. Regular liver function tests should be conducted during treatment, and if any liver dysfunction is suspected, the medication should be discontinued immediately. Symptoms of liver dysfunction include persistent nausea, loss of appetite, fatigue, vomiting, pain in the upper right abdomen, jaundice, dark urine, diarrhea, etc., and if these symptoms occur, notify a doctor immediately. This medication may rarely cause liver failure that could lead to death or require a liver transplant if liver function is severely compromised; therefore, the treatment should be stopped immediately if liver damage progresses. Serious skin reactions may rarely occur in patients taking this medication, so use should be discontinued immediately if any skin rash or unusual symptoms occur. This medication should not be used in patients with specific blood disorders, severe renal failure, nursing mothers, children under 2 years of age, or patients with lactose intolerance. Use with caution in patients with impaired kidney function, elderly patients, and children weighing less than 20 kg; special attention is needed for patients with skin diseases. Common side effects may include gastrointestinal disturbances, headache, myalgia, rash, fatigue, and rare reports of blood abnormalities, liver function abnormalities, and severe allergic reactions. This medication should only be used when a fungal infection is not treatable topically, and if symptoms such as dizziness occur, it is advisable to avoid driving or operating machinery. This medication may interact with other drugs; therefore, if other medications are being taken, be sure to inform a doctor or pharmacist, and dosage adjustments may be necessary. Pregnant women or women who may become pregnant should carefully consider the benefits and risks of using this medication if treatment is necessary, and nursing mothers should discontinue breastfeeding while taking this medication. In cases of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness may occur, and immediate medical attention is required. This medication should be kept out of the reach of children and stored in a cool, dry place away from direct sunlight.
Liver failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, malaise, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous bleeding, leukopenia, anemia, rash, itching, photosensitivity reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasiform rash, psoriasis exacerbation, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial swelling, lymphangiectasia, abdominal distension, decreased appetite, dyspepsia, nausea, mild abdominal pain, diarrhea, discomfort in the stomach area, thirst, vomiting, glossitis, depression, anxiety, headache, loss of taste, taste disturbance, dizziness, drowsiness, sensory abnormalities, sensory loss, decreased attention, insomnia, elevated BUN, increased urinary frequency, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, increased total cholesterol levels, elevated triglycerides, malaise, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, vision decline, hearing loss, auditory impairment, vasculitis, permanent anosmia, hyposmia, eosinophilia, drug rash, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain room temperature between 1 and 30 degrees Celsius.
White round tablet
30,100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Terbinafine Hydrochloride
Prescription medication
Bioneer Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.